<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7120890/results/search/drug/results.xml">
  <result pre="of capsid (amantadine derivatives, pleconaril), replication (reverse transcriptase inhibitors like" exact="zidovudine" post="or abacavir, nevirapine, etc.), integrase inhibitors, DNA or RNA"/>
  <result pre="proteinase involved in viral polyprotein precursors and assembly/maturation inhibitors (indinavir," exact="ritonavir" post="and rimantadine, etc.). Based on this strategy, numerous compounds"/>
  <result pre="formazan product. After removal of the medium, 100 Î¼l of" exact="dimethyl sulfoxide" post="(DMSO) is added to dissolve the formazan crystals. After"/>
  <result pre="then removed by flowing water and stained with 1% (w/v)" exact="crystal violet" post="solution. The plaques are counted by visual examination and"/>
  <result pre="extracted and purified from the mycelia of Ganoderma lucidum by" exact="ethanol" post="(EtOH) precipitation and DEAE-cellulose column chromatography, displayed antiviral activities"/>
  <result pre="thousands of years to treat hepatitis-B. Bioassay-guided fractionation of the" exact="ethanol" post="extract of the rhizomes led to the isolation of"/>
  <result pre="HSV-1 and HSV-2, and it is also active against an" exact="acyclovir" post="resistant strain of HSV-1 (HSV-1-ACVres) (Schuhmacher et al. 2003)."/>
 </snippets>
</snippetsTree>
